Philips Proposes New Appointment and Re-Appointments to Its Supervisory Board and CEO Re-Appointment

Royal Philips, a global leader in health technology, announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO.

The Supervisory Board will submit to the Annual General Meeting of Shareholders 2026 a proposal to appoint John DeFord (American, 1962) as a new member of the Supervisory Board.

The recommendation for this appointment is based on his extensive experience in the medical device industry as a global technology leader and his deep expertise in regulatory affairs, and quality systems, particularly in the US, as well as his strong track record in innovation and product development.

Mr DeFord currently serves as Chairman and Chief Executive Officer of Samothrace Medical Innovations (since 2021). Until 2021, he was Chief Technology Officer at Becton Dickinson, following senior leadership roles at C.R. Bard. He currently holds non-executive board positions at Nordson Corporation, Globus Medical, Inc., Maravai LifeSciences Holdings, Inc., and Enable Injections Inc.

Also Read: AiThority Interview with Glenn Jocher, Founder & CEO, Ultralytics

The Supervisory Board will also submit proposals for the re-appointment of Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board.

These re-appointments will be recommended given the nominees’ valuable contributions to the Supervisory Board and as proven global business leaders with strong track records across medical and health technology, and digital transformation. Their expertise and leadership will remain of great value as Philips continues to advance its strategic priorities, including innovation, patient safety and disciplined execution, to enable better care for more people.

Marc Harrison (American, 1964), whose second term will expire at the end of the AGM 2026, will step down as member of the Supervisory Board. Mr Harrison joined the Supervisory Board in 2018 and has served two consecutive terms.

Mr Feike Sijbesma, Chairman of Philips’ Supervisory Board, said: “On behalf of the Supervisory Board and the Board of Management, I would like to express our sincere gratitude to Marc Harrison for his valuable counsel and contributions over the past eight years. We welcome John DeFord to Philips’ Supervisory Board. He is a highly regarded global technology leader with extensive experience as a senior MedTech executive, bringing interventional domain knowledge and deep expertise in innovation, technical, regulatory, quality, and U.S. FDA matters.

We recommend the re-appointment of Paul Stoffels, Herna Verhagen and Sanjay Poonen, whose continued service and with their exceptional expertise will further strengthen the Supervisory Board. We are grateful for their ongoing commitment and contributions.”

As previously announced on February 10, 2026, Roy Jakobs (Dutch/German, 1974) is proposed by the Supervisory Board to be re-appointed as its President/CEO and Chairman and member of the Board of Management. The proposal to re-appoint Roy Jakobs reflects the Supervisory Board’s recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth.

Also Read: ​​The Infrastructure War Behind the AI Boom

[To share your insights with us, please write to psen@itechseries.com]